The overall survival rates of stage IV ovarian cancer depend on various factors, such as age, treatment, prognosis and overall health of the patient. Statistics in different sources may also vary according to the population and data collected.
Stage IV cancer means the disease has already spread to distant organs. In most patients diagnosed with stage IV ovarian cancer, the 5-year survival rate is approximately 17%. A 5-year survival rate is the number of patients who live at least five years after the cancer diagnosis. They may go on to live for many more years.
For all types of ovarian cancer taken together, about 75% of women with ovarian cancer live for at least one year after diagnosis. Around 46% of the women with ovarian cancer can live five years after diagnosis if the cancer is detected in earlier stages. Women diagnosed under the age of 65 do better than those who are diagnosed later in life.
What are the survival rates of stage IV ovarian cancers?
The following data gives us the approximate survival statistics of women diagnosed with different types of ovarian cancer:
- Epithelial ovarian cancer: The 5-year relative survival rate for patients diagnosed with stage IV cancer is 31%. Epithelial ovarian tumors develop from the cells that cover the outer surface of the ovary. If epithelial ovarian cancer is diagnosed and treated before the cancer has spread outside the ovary, the prognosis is good. Many cases of more advanced cancer may respond well to treatment, but cancer often comes back (recurs) and further treatment is needed.
- Ovarian stromal tumors: The 5-year relative survival rate for patients diagnosed with ovarian stromal tumors at stage IV is 60%. Ovarian stromal tumors are a rare class of tumors that develop from connective tissue cells that hold the ovary together and cells that produce the female hormones, estrogen and progesterone.
- Ovarian germ cell tumors: The 5-year relative survival rate for patients diagnosed at stage IV is 73%. Ovarian germ cell tumors develop from the cells that produce the ova or eggs. Most germ cell tumors are benign (noncancerous), although some are cancerous and may be life-threatening. These can usually be treated successfully, although there may be a small risk of cancer recurrence and further treatment is needed.
- Fallopian tube carcinoma: The 5-year relative survival rate for patients diagnosed with fallopian tube carcinoma at stage IV is 45%.
What happens in stage IV ovarian cancer?
In stage IV ovarian cancer, the cancer has spread from the ovaries to more distant organs. The subtypes of this stage are:
- Stage IVA: This is when the cancer has spread to the sheets of tissue (called pleura) that line the lungs. There is no spread to other organs, such as the liver, spleen, intestine or lymph nodes outside the abdomen. Stage IVA is usually diagnosed when cancer cells cause fluid to build up between the two sheets of tissue.
- Stage IVB: This is when the cancer has spread to organs or lymph nodes outside the abdomen, which may include the liver or spleen.
Stage IV ovarian cancer is graded in addition to being staged, to show how active it is and how quickly or slowly it grows. Stage IV cancers may be graded if they are treated with surgery. The grades are as follows:
- Grade I (sometimes also called well-differentiated cancer): When seen under a microscope, the cancerous cells are well-differentiated from normal cells. They look darker, with a prominent cell nucleus.
- Grade II (moderately differentiated): Cells in this grade look more abnormal and are expected to grow slightly faster. They have abnormal cell membranes.
- Grade III (poorly differentiated): Cells in this grade cannot be differentiated into individual cells and are most aggressive.
What are treatment options for stage IV ovarian cancers?
Surgery is usually considered the best treatment for stage IV ovarian cancers. Women who have more advanced cancers will often have debulking surgeries. Common treatment options are:
- Debulking surgery: The surgeon will attempt to remove as much mass as possible. Data collected in many studies has demonstrated that the more cancer that is removed, the better the long-term outcome for the patient. Sometimes, the cancer will recur after debulking surgery, in which case it may be useful to debulk the tumor a second time, particularly if a year has passed between the initial surgery and the recurrence.
- Palliative treatment: In patients with very advanced stage IV ovarian cancer, surgery may be used for palliation. This means the surgery is done to ease pain or symptoms, not to eliminate the disease.
- Chemotherapy: Some people can be treated for stage IV ovarian cancer with chemotherapy following abdominal surgery. Patients may be recommended to undergo chemotherapy before surgery to shrink the cancer, followed by another course of chemotherapy after the operation. When surgery is not an option, chemotherapy alone may be used to reduce the tumors and control the cancer spread.
Ovarian cancer grows quickly and can progress from early stages to advanced within a year. In the most common form of ovarian cancer, malignant epithelial carcinoma, cancer cells can grow out of control quickly and spread within weeks or months. It is therefore critical to pay attention to symptoms, as this may help improve chances of being diagnosed early and treated promptly.
Detecting cancer while it is still in the early stages will improve the prognosis. Unfortunately, however, 80% of ovarian cancer patients are not diagnosed until the disease has spread throughout their abdominal cavity. Although the 5-year survival rate for ovarian cancer has improved significantly in the past 30 years, the prognosis for ovarian cancer remains poor overall.
Ovarian Cancer Research Alliance. Stages of Ovarian Cancer. https://ocrahope.org/patients/about-ovarian-cancer/staging/
American Cancer Society. Survival Rates for Ovarian Cancer. https://www.cancer.org/cancer/ovarian-cancer/detection-diagnosis-staging/survival-rates.html
Top How Long Do You Have to Live With Stage IV Ovarian Related Articles
Can You Be Fully Cured of Ovarian Cancer?Around two in ten women with advanced-stage ovarian cancer are effectively cured and survive at least 12 years after the treatment as per the research. Your response to cancer therapy and chances for a cure depend on the type and the staging of ovarian cancer at the time of diagnosis.
carboplatinCarboplatin is a chemotherapy medication used in the treatment of advanced ovarian cancer as a single agent or in combination with other approved chemotherapy drugs. Common side effects of carboplatin include nausea, vomiting, gastrointestinal pain, constipation, diarrhea, oral inflammation (stomatitis), inflammation of mucous membranes (mucositis), bone marrow depression, bleeding, transfusions, infections, pain, weakness (asthenia), and others. Do not use if pregnant or breastfeeding.
Ovarian CancerThere are many types of ovarian cancer, epithelial carcinoma is the most common. Women with a family history of ovarian cancer have an increased risk of developing the disease. Some ovarian cancer symptoms include abdominal pain, nausea, diarrhea, constipation, and abnormal vaginal bleeding, however, they usually do not present until the disease has progressed. Early diagnosis is important for successful treatment.
Ovarian Cancer SlidesOvarian cancer symptoms and signs include abdominal pain, bloating, frequent urination, and a feeling of fullness. Ovarian cancer treatment depends on the stage and may include surgery, chemotherapy, radiation, and targeted therapy.
Ovarian Cancer QuizHow common is ovarian cancer and who is at risk? Take our Ovarian Cancer Quiz to learn the causes, symptoms, and treatment for this disease.
paclitaxelPaclitaxel is a chemotherapy drug used to treat various types of cancers including ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi sarcoma. Common side effects of paclitaxel include blood disorders, bleeding, infections, injection site reaction, leakage of drug out of the vein (extravasation), skin rash, hair loss (alopecia), hypersensitivity reactions, severe allergic reaction (anaphylaxis), severe skin reactions, nausea, vomiting, diarrhea, sore mouth (stomatitis), and others. Do not use if pregnant or breastfeeding.
Rubraca (rucaparib) for Ovarian CancerRubraca is a prescription medicine used for the maintenance treatment or treatment of adults with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. The most common side effects of Rubraca include nausea, tiredness or weakness, vomiting, decrease in hemoglobin (anemia), changes in how food tastes, constipation, decreased appetite, diarrhea, low blood cell counts, mouth sores, and others.
What Are the Main Causes of Ovarian Cancer?Each cell in the body survives, grows, and dies under regulated conditions. The term cancer means an uncontrolled growth of cells.
What Are the Symptoms of Stage 1 Ovarian Cancer?At stage 1 of ovarian cancer, the cancer is present only in the ovaries i.e. it has not spread in any other organs. Signs and symptoms at this stage may include a mass felt in the abdomen, distension or swelling of abdomen, abnormal vaginal bleeding (between menstrual periods or after menopause) and other signs. Stage 1 ovarian cancer has no symptoms in many women, however; often they may not experience symptoms until the cancer has spread significantly.
What Is The Main Cause of Ovarian Cysts?Ovarian cysts are fluid-filled growths that grow on the ovary. Learn the signs of an ovarian cyst, what causes ovarian cysts, how doctors diagnose ovarian cysts, and what you can do to treat an ovarian cyst. Ovarian cancer is cancer of the ovaries that produce eggs. Signs and symptoms of ovarian cancer may include abnormal vaginal bleeding or discharge, abdominal pain, reduced appetite, bloating, pelvic pain, constipation and an increased urge to urinate.
What Was Your First Sign of Ovarian Cancer?Like all types of cancer, ovarian cancer is often asymptomatic. The first signs of ovarian cancer may vary from patient to patient. Typically, ovarian cancer symptoms might appear as common stomach and digestive problems that are often mistaken for minor ailments.
Who Is at High Risk for Ovarian Cancer?The risk of ovarian cancer increases with age. Almost half of the ovarian cancer cases are seen in women older than 63 years of age. Ovarian cancer is the leading cause of gynecological cancer-related deaths among women between the ages of 35 and 74 years.